Ligand id: 9614

Name: crotedumab

Compound class Antibody
International Nonproprietary Names
INN number INN
10196 crotedumab
REGN-1193 | REGN1193
Crotedumab (REGN1193) is a fully human IgG4 monoclonal antibody that functionally antagonises activity of the glucagon receptor (GCGR) in vitro [1]. REGN1193 was investigated as a potential therapy for type 2 diabetes mellitus.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
This mAb is no longer included in Regeneron's development pipeline (access their pipeline webpage here).
Database Links
Specialist databases
IMGT/mAb-DB 595
Other databases
GtoPdb PubChem SID 340590244
Search PubMed clinical trials crotedumab
Search PubMed titles crotedumab
Search PubMed titles/abstracts crotedumab